SCHEMBL4764607

SCHEMBL4764607

Cc1ccc2c(S(=O)(=O)Oc3c(Cl)cc(S(=O)(=O)O)c4ccc(C)nc34)ccc(O)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.41
HTT P42858 3/20 0.41
PKM P14618 1/20 0.41
KMT2A Q03164 6/20 0.41
OPRK1 P41145 1/20 0.41
GAA P10253 1/20 0.40
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
CTSB P07858 1/20 0.38
CTSH P09668 1/20 0.38
LMNA P02545 2/20 0.38
COMT P21964 1/20 0.37
NPSR1 Q6W5P4 1/20 0.35
CCR6 P51684 1/20 0.34
ATM Q13315 1/20 0.34
TSHR P16473 1/20 0.34
POLB P06746 1/20 0.34
RECQL P46063 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4764600 0.82 MAPT (0.56) KDM4EHTTPKMKMT2AOPRK1
SCHEMBL1029385 0.79 KMT2A (0.59) KDM4EKMT2AOPRK1ALDH1A1MEN1
SCHEMBL1076730 0.77 MAPT (0.65) KDM4EHTTPKMKMT2AOPRK1
SCHEMBL7944048 0.73 MAPT (0.67) KDM4EHTTPKMKMT2AOPRK1
SCHEMBL27638396 0.72 OPRK1 (0.57) KDM4EKMT2AOPRK1ALDH1A1MAPT
SCHEMBL11316137 0.70 COMT (0.76) KDM4EHTTKMT2AOPRK1ALDH1A1
SCHEMBL4293438 0.69 KMT2A (0.65) KDM4EHTTPKMKMT2AOPRK1
SCHEMBL21034060 0.68 KDM4E (0.56) KDM4EHTTPKMKMT2AGAA
SCHEMBL30961312 0.68 OPRK1 (0.54) KDM4EHTTKMT2AOPRK1ALDH1A1
SCHEMBL7692195 0.67 KMT2A (0.67) KDM4EHTTPKMKMT2AOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904482-A2 INDOLYLMALEIMIDE DERIVATIVES Novartis AG (CH) 2008-04-02 EP disclosed
WO-2007006533-A2 INDOLYLMALEIMIDE DERIVATIVES NOVARTIS AG (CH) 2007-01-18 WO disclosed